Episode 122: Nurtured Nuts: Bryant Williams on Winning Pitch Competitions, the Anatomy of a 5-Minute Pitch, and Gene-Editing the Allergens Out of Peanuts In this episode, I sit down with Bryant Williams, Founder & CEO of Nurtured Nuts Company — the Minnesota-based food-tech startup commercializing the allergen-less peanuts created by AgriNetica's gene-editing (CRISPR) and bringing them back to the schools, airlines, and restaurants that banned them. Just weeks before we spoke, Bryant took first place at IFT FIRST's "The Pitch!" competition in Chicago — his fourth pitch-competition win — so we turned this into a genuine masterclass on the single most underrated founder skill: pitching. Bryant walks through his exact 5-minute pitch, beat by beat, and explains the thinking behind each move: why he opens with a 14-word one-liner in the first fifteen seconds; how he builds an emotional "hook" that makes even the peanut itself a character worth rooting for; how he frames the solution, the market (a ~2BUSpeanut-buttermarket,~200M in restricted food-service, and a secondary opportunity he sizes north of a trillion), the products and business model, the scientific credibility, and the go-to-market; and how he "lands the plane" with an ask that turns the whole room into potential partners. We also get his practical preparation playbook — mirror reps and timed run-throughs, knowing your audience, researching the judges, and slowing down because "you have more time than you realize." 🎧 Listen to the full masterclass to hear the exact line Bryant closes every pitch with ("I've shared a lot with you — but the most important thing I'm missing is you"), why concise beats comprehensive, how he makes nostalgia do the selling, and where Nurtured Nuts is on its path to the first commercially available allergen-less peanut. Key Facts: Nurtured Nuts Company Bryant Williams (Founder & CEO): https://www.linkedin.com/in/bryant-c-williamsWebsite: https://www.nurturednuts.com/Based: Minnesota (Minneapolis), USAWhat They Do: Commercialize AgriNetica's peanut, gene-edited to remove the three clinically relevant proteins responsible for the anaphylactic response in peanuts — creating an allergen-less peanut that can re-enter "restricted" markets (schools, airlines, restaurants) while preserving flavor, nutrition, and versatility.Recognition: Grand-prize winner of "The Pitch!" at IFT FIRST 2026 in Chicago ($10,000 prize) — Bryant's fourth pitch-competition win (also Bend Venture Conference 2024, a Sango virtual competition, and Summerfest Tech AI in Milwaukee). Blurb NURTURED NUTS COMPANY is chasing something that sounds impossible and feels inevitable: a peanut that can't hurt you. Using second-generation gene-editing, AgriNetica — which owns the gene-editing technology and IP — has removed the three clinically relevant proteins behind the anaphylactic response, "rebuilt the peanut," and — with USDA approval and a Georgia field planting — begun what's reported as the first commercial-scale outdoor cultivation of gene-edited peanuts in the U.S. The prize isn't just safety; it's category re-creation. Peanuts once lived on every lunch table, plane, and ballpark before allergy risk exiled them. Nurtured Nuts wants to bring them back — and open entirely new doors in beverages, confectionery, snacks, and sports nutrition along the way. AgriNetica developed the peanut — it owns the gene-editing technology and IP, and runs the clinical and scientific work. Nurtured Nuts is the commercialization partner (sales, manufacturing, distribution, marketing).
